In his May 16 report, Yeo writes that Frencken’s 1QFY2024 revenue and earnings had met his expectations, and he believes the company will continue to strengthen its revenue due to it being a “beneficiary of the anticipated semiconductor recovery” going forward.
Analysts at Maybank Securities, RHB Bank Singapore and UOB Kay Hian Research have all maintained their “buy” calls on Frencken Group (SGX:E28
) following the company’s strong 1QFY2024 ended March results.
While Maybank and UOBKH have both kept their target prices of $1.77 and $1.74 unchanged, RHB analyst, Alife Yeo has raised his target price $1.81 from $1.80 previously.
